Use of Angiotensin Receptor Blockers In Cardiovascular Protection: Current Evidence and Future Directions

Por Munger, Mark A.
Publicado em 2011

Primary Care Pharmacists: Provision of Clinical-Decision Services in Healthcare

Por Munger, Mark A.
Publicado em 2014

Redes locais novell netware manual do usuário /

Por Christiansen, Paul., King, Steve., Munger, Mark.
Publicado em 1990

Medication Nonadherence: An Unrecognized Cardiovascular Risk Factor

Por Munger, Mark A., Van Tassell, Benjamin W., LaFleur, Joanne
Publicado em 2007

Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular α(1)-adrenoreceptor signal...

Por Van Tassell, Benjamin W., Rondina, Matthew T., Huggins, Franklin, Gilbert, Edward M., Munger, Mark A.
Publicado em 2008

In Vivo Human Time-Exposure Study of Orally Dosed Commercial Silver Nanoparticles

Por Munger, Mark A., Radwanski, Przemyslaw, Hadlock, Greg C., Stoddard, Greg, Shaaban, Akram, Falconer, Jonathan, Grainger, David W., Deering-Rice, Cassandra E.
Publicado em 2013

Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains

Por Feehan, Michael, Munger, Mark A., Cooper, Daniel K., Hess, Kyle T., Durante, Richard, Jones, Gregory J., Montuoro, Jaime, Morrison, Margaux A., Clegg, Daniel, Crandall, Alan S., DeAngelis, Margaret M.
Publicado no J Clin Med (2016)

A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy

Por Beddhu, Srinivasan, Filipowicz, Rebecca, Wang, Bin, Wei, Guo, Chen, Xiaorui, Roy, Abinash C., DuVall, Scott L., Farrukh, Hanadi, Habib, Arsalan N., Bjordahl, Terrence, Simmons, Debra L., Munger, Mark, Stoddard, Greg, Kohan, Donald E., Greene, Tom, Huang, Yufeng
Publicado no Can J Kidney Health Dis (2016)